Immunotherapy Targeting α-Synuclein, with Relevance for Future Treatment of Parkinson‘s Disease and Other Lewy Body Disorders

DOI Web Site 1 Citations
  • Veronica Lindström
    Department of Public Health/Geriatrics, Rudbeck Laboratory, Uppsala University, 751 85Uppsala, Sweden
  • Elisabet Ihse
    Department of Public Health/Geriatrics, Rudbeck Laboratory, Uppsala University, 751 85Uppsala, Sweden
  • Therese Fagerqvist
    Department of Public Health/Geriatrics, Rudbeck Laboratory, Uppsala University, 751 85Uppsala, Sweden
  • Joakim Bergström
    Department of Public Health/Geriatrics, Rudbeck Laboratory, Uppsala University, 751 85Uppsala, Sweden
  • Eva Nordström
    BioArctic Neuroscience AB, Stockholm, Sweden
  • Christer Möller
    BioArctic Neuroscience AB, Stockholm, Sweden
  • Lars Lannfelt
    Department of Public Health/Geriatrics, Rudbeck Laboratory, Uppsala University, 751 85Uppsala, Sweden
  • Martin Ingelsson
    Department of Public Health/Geriatrics, Rudbeck Laboratory, Uppsala University, 751 85 Uppsala, Sweden. Tel.: Fax:

Journal

  • Immunotherapy

    Immunotherapy 6 (2), 141-153, 2014-02

    Informa UK Limited

Citations (1)*help

See more

Details 詳細情報について

Report a problem

Back to top